Blood harmane is correlated with cerebellar metabolism in essential tremor: A pilot study

Neurology

Volumn 69, Issue 6, 2007, Pages 515-520

  Louis, Elan D ^a,b,e   Zheng, Wei ^c   Mao, Xiangling ^d   Shungu, Dikoma C ^d  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Purdue University School of Health Sciences ^*  (United States)

^c PURDUE UNIVERSITY   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HARMAN; LEAD; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; HARMINE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE; NEUROTOXIN; UNCLASSIFIED DRUG;

ARTICLE; BASAL GANGLION; BRAIN METABOLISM; CEREBELLUM CORTEX; CEREBELLUM VERMIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; ESSENTIAL TREMOR; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THALAMUS; WHITE MATTER; BLOOD; CEREBELLUM; CHEMISTRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE; PILOT STUDY; SINGLE BLIND PROCEDURE; VIDEORECORDING;

ASPARTIC ACID; BASAL GANGLIA; CEREBELLAR CORTEX; CEREBELLUM; CREATINE; ESSENTIAL TREMOR; FEMALE; HARMINE; HUMANS; LEAD; MALE; NEUROTOXINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PILOT PROJECTS; SINGLE-BLIND METHOD; THALAMUS; VIDEOTAPE RECORDING;

EID: 34548435723     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000266663.27398.9f     Document Type: Article

References (41)

1. Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord 1998;13:5-10.
2. Dogu O, Sevim S, Camdeviren H, et al. Prevalence of essential tremor: door-to-door neurological exams in Mersin Province, Turkey. Neurology 2003;61:1804-1807.
3. Benito-Leon J, Bermejo-Pareja F, Louis ED. Incidence of essential tremor in three elderly populations of central Spain. Neurology 2005;64:1721-1725.
4. Louis ED, Shungu D, Chan S, Mao X, Jurewicz EC, Watner D. Metabolic abnormality in patients with essential tremor: A proton magnetic resonance spectroscopic imaging study. Neurosci Lett 2002;333:17-20.
5. Louis ED, Vonsattel JPG, Honig LS, Ross GW, Lyons KE, Pahwa R. Neuropathological findings in essential tremor. Neurology 2006;66:1756-1759.
6. Louis ED, Vonsattel JPG, Honig LS, et al. Essential tremor associated with pathological changes in the cerebellum. Arch Neurol 2006;63:1189-1193.
7. Higgins JJ, Loveless JM, Jankovic J, Patel PI. Evidence that a gene for essential tremor maps to chromosome 2p in four families 1998;13:972-977.
8. Tanner CM, Goldman SM, Lyons KE, et al. Essential tremor in twins: an assessment of genetic vs. environmental determinants of etiology. Neurology 2001;57:1389-1391.
9. Louis ED. Etiology of essential tremor: should we be searching for environmental causes? Mov Disord 2001;16:822-829.
10. De Meester C. Genotoxic potential of beta-carbolines: a review. Mut Res 1995;339:139-153.
11. Zetler G, Singbartl G, Schlosser L. Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids. Pharmacology 1972;7:237-248.
12. Pfau W, Skog K. Exposure to beta-carbolines norharman and harman. J Chromatog B 2004;802:115-126.
13. Gross GA, Gruter A. Quantitation of mutagenic/carcinogenic heterocyclic aromatic amines in food products. J Chromatog A 1992;592:271-278.
14. Herraiz T. Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit Contam 2004;21:1041-1050.
15. Olsson V, Solyakov A, Skog K, Lundstrom K, Jagerstad M. Natural variations of precursors in pig meat affect the yield of heterocyclic amines: effects of RN genotype, feeding regime, and sex. J Agric Food Chem 2002;50:2962-2969.
16. Martin FC, Thu Le, A Handforth A. Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov Disord 2005;20:298-305.
17. Handforth A, Krahl SE. Suppression of harmaline-induced tremor in rats by vagus nerve stimulation. Mov Disord 2001;16:84-88.
18. O'Hearn E, Molliver ME. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 1993;55:303-310.
19. Skog K, Augustsson K, Steineck G, Steinberg M, Jagerstad M. Polar and non-polar heterocyclic amines in cooked fish and meat products and their corresponding pan residues. Food Chem Toxicol 1997;35:555-565.
20. Skog K, Solyakov A, Arvidsson P, Jagerstad M. Analysis of nonpolar hetrocyclic amines in cooked foods and meat extracts using gas chromatography-mass spectrometry. J Chromatog A 1998;803:227-233.
21. Louis ED, Zheng W, Jurewicz EC, et al. Elevation of blood β-carboline alkaloids in essential tremor. Neurology 2002;59:1940-1944.
22. Louis ED, Zheng W, Applegate L, Shi L, Factor-Litvak P. Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology 2005;65:391-396.
23. Rommelspacher H, Damm H, Strauss S, Schmidt G. Ethanol induces an increase of Harman in the brain and urine of rats. Naunyn Schmiedebergs Arch Pharmacol 1984;327:107-113.
24. Guan Y, Louis ED, Zheng W. Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. J Toxicol Environ Health 2001;64:101-116.
25. 3H]harmane, an endogenous β-carboline, in rat brain. Neuropharmacology 2006;50:269-276.
26. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-117.
27. Duyn JH, Gillen J, Sobering G, van Zijl PCM, Moonen CTW. Multisection proton MR spectroscopic imaging of the brain, Radiology 1993;188:277-282.
28. Rommelspacher H, Schmidt LG, May T. Plasma norharman (β-carboline) levels are elevated in chronic alcoholics. Alcohol Clin Exp Res 1991;15:553-559.
29. Zheng W, Wang S, Barnes LF, Guan Y, Louis ED. Determination of harmane and harmine in human blood using reversed-phase high-performance liquid chromatography and fluorescence detection. Anal Biochem 2000;279:125-129.
30. Louis ED, Jurewicz EC, Applegate L, et al. Association between essential tremor and blood lead concentration. Environ Health Perspect 2003;111:1707-1711.
31. Harada M, Miyoshi H, Otsuka H, Nishitani H, Uno M. Multivariate analysis of regional metabolic differences in normal ageing on localized quantitative proton MR spectroscopy. Neuroradiology 2001;43:448-453.
32. Driscoll I, Hamilton DA, Petropoulos H, et al. The aging hippocampus: cognitive, biochemical and structural findings. Cerebral Cortex 2003;13:1344-1351.
33. Sijens PE, Heijer Ed, Origgi D, et al. Brain changes with aging: MR spectroscopy at supraventricular plane shows differences between women and men. Neuroradiology 2003;226:889-896.
34. Constantinidis I. Magnetic resonance spectroscopy and the practicing neurologist. Neurologist 1998;4:77-98.
35. Pagan FL, Butman JA, Dambrosia JM, Hallett M. Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 2003;60:1344-1347.
36. Du W, Aloyo VJ, Harvey JA. Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain. Brain Res 1997;770:26-29.
37. O'Hearn E, Molliver ME. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity. J Neurosci 1997;17:8828-8841.
38. Rommelspacher H, May T, Salewski B. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur J Pharmacol 1994;252:51-59.
39. Rommelspacher H, Wiest M, Neuhaus R, Platzgummer W, Schmidt LG, Neuhaus P. Long-term changes of markers of alcoholism after orthotopic liver transplantation (OLT). Transplantation 1996;62:1451-1455.
40. Callaway JC, Airaksinen MM, Salmela KS, Salaspuro M. Formation of tetrahydroharman (1-methyl-1,2,3,4-tetrahydro-beta-carboline) by Helicobacter pylori in the presence of ethanol and tryptamine. Life Sci 1996;58:1817-1821.
41. Yu AM, Idle JR, Krausz KW, Kupfer A, Gonzalez FJ. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther 2003;305:315-322.